| Literature DB >> 35845937 |
Jimba Jatsho1, Dorji Pelzom2, Sithar Dorji3, Thinley Pelzang3.
Abstract
Introduction: The transmission trend of SARS-CoV-2 is continuously evolving. Understanding the dynamics in different settings is crucial for any effective containment measures. We aimed to study the characteristics of household transmission of SARS-CoV-2 in Bhutanese households by determining the transmissibility within household contacts of confirmed COVID-19 index cases and their factors of infectivity.Entities:
Mesh:
Year: 2022 PMID: 35845937 PMCID: PMC9286897 DOI: 10.1155/2022/5644454
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Flow algorithm of household cases.
Demographic characteristics of index cases and their household contacts in Phuentsholing, Bhutan.
| Characteristics | Index case ( | Household contacts ( | ||
|---|---|---|---|---|
|
| % |
| % | |
| Age | ||||
| <18 years | 13 | 14.0 | 123 | 40.2 |
| 18-44 years | 66 | 71.0 | 146 | 47.7 |
| 45-59 years | 10 | 10.8 | 23 | 7.5 |
| ≥60 years | 4 | 4.3 | 14 | 4.6 |
| Sex | ||||
| Male | 46 | 49.5 | 131 | 42.8 |
| Female | 47 | 50.5 | 175 | 57.2 |
| High risk | ||||
| Yes | 25 | 26.9 | 0 | 0.0 |
| No | 68 | 73.1 | 0 | 0.0 |
| Clinical status | ||||
| Symptomatic | 72 | 77.4 | 105 | 34.3 |
| Asymptomatic | 21 | 22.6 | 201 | 65.7 |
| Symptom status | ||||
| Mild | 72 | 100.0 | 102 | 97.1 |
| Moderate | 0 | 0.0 | 3 | 2.9 |
| Household size | ||||
| ≤3 members | 40 | 43.0 | — | — |
| 4-6 members | 42 | 45.2 | — | — |
| ≥7members | 11 | 11.8 | — | — |
| Comorbid | ||||
| Yes | 7 | 7.5 | 17 | 5.6 |
| No | 86 | 92.5 | 289 | 94.4 |
| Vaccination (≥18 years) | ||||
| Yes | 76 | 95.0 | 178 | 97.3 |
| No | 4 | 5.0 | 5 | 2.7 |
| Doses | ||||
| 1 dose | 76 | 100.0 | 179 | 100.0 |
| 2 doses | 0 | 0.0 | 0 | 0.0 |
Characteristics of secondary transmission of COVID-19 in households.
| Characteristics | Household contacts ( | Positive household contacts ( | Secondary attack rate (%) | 95% CI |
|---|---|---|---|---|
|
| ||||
| Age | ||||
| <18 years | 123 | 78 | 63.4 | (54.5-71.5) |
| ≥18 years | 183 | 102 | 55.7 | |
| 18-44 years | 146 | 78 | 53.4 | (44.1-61.4) |
| 45-59 years | 23 | 16 | 69.6 | (47.9-85) |
| ≥60 years | 14 | 8 | 57.1 | (30.7-80.1) |
| Sex | ||||
| Male | 131 | 78 | 59.5 | (50.9-67.7) |
| Female | 175 | 102 | 58.3 | (50.8-65.4) |
| Relationship to the index case | ||||
| Spouse | 47 | 26 | 55.3 | (40.9-68.9) |
| Siblings | 39 | 16 | 41 | (26.7-57.1) |
| Child | 99 | 72 | 72.7 | (63.1-80.6) |
| Parents | 28 | 15 | 53.6 | (35.1-71.1) |
| Relatives (grandparents, cousins, others) | 47 | 22 | 46.8 | (33-61.1) |
| Friend/neighbor | 39 | 26 | 66.7 | (50.4-79.7) |
| Employee | 7 | 3 | 42.9 | (12.9-79.2) |
| Clinical status | ||||
| Symptomatic | 105 | 104 | 99 | (93.4-99.9) |
| Asymptomatic | 201 | 76 | 37.8 | (31.3-44.8) |
| Symptom status | ||||
| Mild | 102 | 101 | 99 | (93.2-99.9) |
| Moderate | 3 | 3 | 100 | — |
| Comorbid | ||||
| Yes | 17 | 10 | 58.8 | (34.5-79.5) |
| No | 289 | 170 | 58.8 | (53-64.4) |
| Vaccination | ||||
| Yes | 179 | 99 | 55.3 | (47.9-62.5) |
| No | 127 | 81 | 63.8 | (55-71.7) |
| Vaccination (≥18 years of age) | ||||
| Yes | 178 | 98 | 55.1 | (47.6-62.3) |
| No | 5 | 4 | 80 | (25.3-97.9) |
| Doses | ||||
| 1 dose | 179 | 99 | 55.3 | (47.9-62.5) |
| Past COVID infection | ||||
| Yes | 1 | 0 | 0 | — |
| No | 305 | 180 | 59 | (53.4-64.4) |
|
| ||||
| Age of index case | ||||
| <18 years | 39 | 13 | 33.3 | (20.3-49.6) |
| ≥18 years | 267 | 167 | 62.5 | (56.6-68.2) |
| Index case sex | ||||
| Male | 156 | 91 | 58.3 | (50.4-65.9) |
| Female | 150 | 89 | 59.3 | (51.2-67) |
| Symptom status of index case | ||||
| Symptomatic index | 233 | 142 | 60.9 | (54.5-67) |
| Asymptomatic index | 73 | 38 | 52.1 | (40.6-63.3) |
| Vaccination status of index case | ||||
| Yes | 257 | 167 | 65 | (58.9-70.6) |
| No | 49 | 13 | 26.5 | (16-40.7) |
Unadjusted prevalence ratio of risk factors for infectivity of SARS-CoV-2.
| Risk factors |
| uPR (95% CI) |
|
|---|---|---|---|
|
| |||
| Age | |||
| <18 years | 123 | 1 | |
| ≥18 years | 183 | 0.88 (0.73,1.06) | 0.174 |
| Sex | |||
| Male | 131 | 1 | |
| Female | 175 | 0.98 (0.81, 1.18) | 0.825 |
| Relationship | |||
| Spouse | 47 | 1 | |
| Relatives | 83 | 0.81 (0.57, 1.15) | 0.229 |
| Child | 99 | 1.31 (0.99, 1.75) | 0.059 |
| Parents/grandparents | 31 | 0.93 (0.61, 1.43) | 0.75 |
| Others (neighbors/friends/employers) | 46 | 1.14 (0.81, 1.6) | 0.45 |
| Comorbidity | |||
| Yes | 17 | 1 | |
| No | 289 | 1 (0.66, 1.51) | 1 |
| Vaccination | |||
| Yes | 179 | 1 | |
| No | 127 | 1.15 (0.96, 1.39) | 0.133 |
| Household size (categorical) | |||
| ≤3 members | 64 | 1 | |
| 4-6 members | 155 | 1.07 (0.83, 1.39) | 0.591 |
| ≥7 members | 87 | 1.13 (0.86, 1.5) | 0.37 |
| Household size | 306 | (0.95, 1.02) | 0.426 |
| Age | 306 | 1 (0.99, 1) | 0.396 |
|
| |||
| Age of index case | |||
| <18 years | 39 | 1 | |
| ≥18 years | 267 | 1.88 (1.19, 2.95) | 0.007 |
| Index case sex | |||
| Male | 156 | 1 | |
| Female | 150 | 1.02 (0.84, 1.22) | 0.859 |
| Symptom status of index case | |||
| Symptomatic index | 233 | 1 | |
| Asymptomatic index | 73 | 0.85 (0.67, 1.09) | 0.203 |
| Vaccination status of index case | |||
| Yes | 257 | 1 | |
| No | 49 | 0.408 (0.25, 0.66) | <0.001 |
uPR: unadjusted prevalence ratio. 1: reference value. ∗p values were calculated using the generalized linear models for binomial family.
Adjusted prevalence ratio for factors of infectivity.
| Factors∗ |
| aPR (95% CI) |
|
|---|---|---|---|
| Age of index case | 93 | 1 (1, 1.02) | 0.01 |
| Age of contact | |||
| <18 years | 123 | 1 | |
| 18-44 years | 146 | 1.3 (0.66, 2.46) | 0.476 |
| 45-59 years | 23 | 1.5 (0.72, 3.33) | 0.264 |
| ≥60 years | 14 | 1.3 (0.58, 2.73) | 0.557 |
| Symptom status of index case | |||
| Symptomatic | 233 | 1 | |
| Asymptomatic | 73 | 0.8 (0.66, 1.04) | 0.107 |
| Relationship | |||
| Spouse | 47 | 1 | |
| Relatives | 83 | 0.9 (0.63, 1.3) | 0.599 |
| Child | 99 | 1.3 (0.91, 1.94) | 0.139 |
| Parents/grandparents | 31 | 1.3 (0.78, 2.01) | 0.352 |
| Others (neighbors/friends/employers) | 46 | 1.3 (0.91, 1.82) | 0.152 |
| Vaccination (contacts) | |||
| Yes | 179 | 1 | |
| No | 127 | 1.4 (0.72, 2.58) | 0.335 |
aPR: adjusted prevalence ratio. 1: reference value ∗The variables with p value ≤ 0.2 from unadjusted regression analysis were taken into consideration for this model.